Ultrasound Doppler measurements predict success of treatment with anti-TNF-α drug in patients with rheumatoid arthritis: a prospective cohort study

Karen Ellegaard; Robin Christensen; Søren Torp-Pedersen; Lene Terslev; Christian C Holm; Merete J Kønig; Peter S Jensen; Bente Danneskiold-Samsøe; Henning Bliddal

doi:10.1093/rheumatology/keq336

Ultrasound Doppler measurements predict success of treatment with anti-TNF-α drug in patients with rheumatoid arthritis: a prospective cohort study

Karen Ellegaard, Robin Christensen, Søren Torp-Pedersen, Lene Terslev, Christian C Holm, Merete J Kønig, Peter S Jensen, Bente Danneskiold-Samsøe, Henning Bliddal

The Parker Institute

42 Citations (Scopus)

Abstract

To investigate the predictive ability of core outcomes applied in RA trials, including ultrasound (US) Doppler (USD) measurements differentiating patients who remain on anti-TNF-α therapy following 1 year.

Original language	English
Journal	Rheumatology
Volume	50
Issue number	3
Pages (from-to)	506-12
Number of pages	7
ISSN	1462-0324
DOIs	https://doi.org/10.1093/rheumatology/keq336
Publication status	Published - 2011

Keywords

Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Arthritis, Rheumatoid
Female
Humans
Immunoglobulin G
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Receptors, Tumor Necrosis Factor
Time Factors
Treatment Outcome
Tumor Necrosis Factor-alpha
Ultrasonography, Doppler
Wrist Joint

Access to Document

10.1093/rheumatology/keq336

Cite this

Ellegaard, K., Christensen, R., Torp-Pedersen, S., Terslev, L., Holm, C. C., Kønig, M. J., Jensen, P. S., Danneskiold-Samsøe, B., & Bliddal, H. (2011). Ultrasound Doppler measurements predict success of treatment with anti-TNF-α drug in patients with rheumatoid arthritis: a prospective cohort study. Rheumatology, 50(3), 506-12. https://doi.org/10.1093/rheumatology/keq336

Ellegaard, K , Christensen, R, Torp-Pedersen, S, Terslev, L , Holm, CC , Kønig, MJ, Jensen, PS, Danneskiold-Samsøe, B & Bliddal, H 2011, 'Ultrasound Doppler measurements predict success of treatment with anti-TNF-α drug in patients with rheumatoid arthritis: a prospective cohort study', Rheumatology, vol. 50, no. 3, pp. 506-12. https://doi.org/10.1093/rheumatology/keq336

@article{2a18a8ac35f5494d98d837e4abd2bfa3,

title = "Ultrasound Doppler measurements predict success of treatment with anti-TNF-α drug in patients with rheumatoid arthritis: a prospective cohort study",

abstract = "To investigate the predictive ability of core outcomes applied in RA trials, including ultrasound (US) Doppler (USD) measurements differentiating patients who remain on anti-TNF-α therapy following 1 year.",

keywords = "Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Rheumatoid, Female, Humans, Immunoglobulin G, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Receptors, Tumor Necrosis Factor, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha, Ultrasonography, Doppler, Wrist Joint",

author = "Karen Ellegaard and Robin Christensen and S{\o}ren Torp-Pedersen and Lene Terslev and Holm, \{Christian C\} and K{\o}nig, \{Merete J\} and Jensen, \{Peter S\} and Bente Danneskiold-Sams{\o}e and Henning Bliddal",

year = "2011",

doi = "10.1093/rheumatology/keq336",

language = "English",

volume = "50",

pages = "506--12",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Ultrasound Doppler measurements predict success of treatment with anti-TNF-α drug in patients with rheumatoid arthritis

T2 - a prospective cohort study

AU - Ellegaard, Karen

AU - Christensen, Robin

AU - Torp-Pedersen, Søren

AU - Terslev, Lene

AU - Holm, Christian C

AU - Kønig, Merete J

AU - Jensen, Peter S

AU - Danneskiold-Samsøe, Bente

AU - Bliddal, Henning

PY - 2011

Y1 - 2011

N2 - To investigate the predictive ability of core outcomes applied in RA trials, including ultrasound (US) Doppler (USD) measurements differentiating patients who remain on anti-TNF-α therapy following 1 year.

AB - To investigate the predictive ability of core outcomes applied in RA trials, including ultrasound (US) Doppler (USD) measurements differentiating patients who remain on anti-TNF-α therapy following 1 year.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Antirheumatic Agents

KW - Arthritis, Rheumatoid

KW - Female

KW - Humans

KW - Immunoglobulin G

KW - Male

KW - Middle Aged

KW - Predictive Value of Tests

KW - Prospective Studies

KW - Receptors, Tumor Necrosis Factor

KW - Time Factors

KW - Treatment Outcome

KW - Tumor Necrosis Factor-alpha

KW - Ultrasonography, Doppler

KW - Wrist Joint

UR - https://www.scopus.com/pages/publications/79952017182

U2 - 10.1093/rheumatology/keq336

DO - 10.1093/rheumatology/keq336

M3 - Journal article

C2 - 21071479

SN - 1462-0324

VL - 50

SP - 506

EP - 512

JO - Rheumatology

JF - Rheumatology

IS - 3

ER -

Ultrasound Doppler measurements predict success of treatment with anti-TNF-α drug in patients with rheumatoid arthritis: a prospective cohort study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this